374 related articles for article (PubMed ID: 37803464)
1. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment.
Peroni E; Randi ML; Rosato A; Cagnin S
J Exp Clin Cancer Res; 2023 Oct; 42(1):259. PubMed ID: 37803464
[TBL] [Abstract][Full Text] [Related]
2. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
Zhou J; Chng WJ
Front Oncol; 2024; 14():1365330. PubMed ID: 38711849
[TBL] [Abstract][Full Text] [Related]
3. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
Marofi F; Rahman HS; Al-Obaidi ZMJ; Jalil AT; Abdelbasset WK; Suksatan W; Dorofeev AE; Shomali N; Chartrand MS; Pathak Y; Hassanzadeh A; Baradaran B; Ahmadi M; Saeedi H; Tahmasebi S; Jarahian M
Stem Cell Res Ther; 2021 Aug; 12(1):465. PubMed ID: 34412685
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia.
Zhai Y; Singh P; Dolnik A; Brazda P; Atlasy N; Del Gaudio N; Döhner K; Döhner H; Minucci S; Martens J; Altucci L; Megchelenbrink W; Bullinger L; Stunnenberg HG
Mol Cancer; 2022 Aug; 21(1):166. PubMed ID: 35986270
[TBL] [Abstract][Full Text] [Related]
5. Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome.
Jiang L; Li XP; Dai YT; Chen B; Weng XQ; Xiong SM; Zhang M; Huang JY; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20117-20126. PubMed ID: 32747558
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
[TBL] [Abstract][Full Text] [Related]
7. Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.
Wang J; Lu R; Wu Y; Jia J; Gong L; Liu X; Lu S; Wang Y; Yan C; Liu K; Zhang X; Xu L; Jiang Q; Zhao X; Shi H; Lai Y; Huang X; Ruan G; Jiang H
Br J Haematol; 2020 Aug; 190(4):533-544. PubMed ID: 32090321
[TBL] [Abstract][Full Text] [Related]
8. Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy.
Hu X; Cao D; Zhou Z; Wang Z; Zeng J; Hong WX
Cell Oncol (Dordr); 2024 Feb; 47(1):97-112. PubMed ID: 37615858
[TBL] [Abstract][Full Text] [Related]
9. Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing.
Chen A; Hu S; Wang QF
Blood Sci; 2019 Aug; 1(1):73-76. PubMed ID: 35402804
[TBL] [Abstract][Full Text] [Related]
10. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
11. CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Cui Q; Qian C; Xu N; Kang L; Dai H; Cui W; Song B; Yin J; Li Z; Zhu X; Qu C; Liu T; Shen W; Zhu M; Yu L; Wu D; Tang X
J Hematol Oncol; 2021 May; 14(1):82. PubMed ID: 34034795
[TBL] [Abstract][Full Text] [Related]
12. Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Trad R; Warda W; Alcazer V; Neto da Rocha M; Berceanu A; Nicod C; Haderbache R; Roussel X; Desbrosses Y; Daguindau E; Renosi F; Roumier C; Bouquet L; Biichle S; Guiot M; Seffar E; Caillot D; Depil S; Robinet E; Salma Y; Deconinck E; Deschamps M; Ferrand C
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35803613
[TBL] [Abstract][Full Text] [Related]
13. Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia.
Schorr C; Perna F
Front Immunol; 2022; 13():1085978. PubMed ID: 36605213
[TBL] [Abstract][Full Text] [Related]
14. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
Minagawa K; Jamil MO; Al-Obaidi M; Pereboeva L; Salzman D; Erba HP; Lamb LS; Bhatia R; Mineishi S; Di Stasi A
PLoS One; 2016; 11(12):e0166891. PubMed ID: 27907031
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia.
Li Z; Liu X; Wang L; Zhao H; Wang S; Yu G; Wu D; Chu J; Han J
Front Immunol; 2023; 14():1281687. PubMed ID: 38022588
[TBL] [Abstract][Full Text] [Related]
17. Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.
Perna F; Espinoza-Gutarra MR; Bombaci G; Farag SS; Schwartz JE
Cancer Treat Res; 2022; 183():225-254. PubMed ID: 35551662
[TBL] [Abstract][Full Text] [Related]
18. Demethylating therapy increases cytotoxicity of CD44v6 CAR-T cells against acute myeloid leukemia.
Tang L; Kong Y; Wang H; Zou P; Sun T; Liu Y; Zhang J; Jin N; Mao H; Zhu X; Wang J; Meng F; You Y
Front Immunol; 2023; 14():1145441. PubMed ID: 37180104
[TBL] [Abstract][Full Text] [Related]
19. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
[TBL] [Abstract][Full Text] [Related]
20. Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patients.
Zeller C; Richter D; Jurinovic V; Valtierra-Gutiérrez IA; Jayavelu AK; Mann M; Bagnoli JW; Hellmann I; Herold T; Enard W; Vick B; Jeremias I
J Hematol Oncol; 2022 Mar; 15(1):25. PubMed ID: 35279202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]